NS-089/NCNP-02 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	2

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05135663 (ClinicalTrials.gov)	June 23, 2021	5/10/2021	Extension Study of NS-089/NCNP-02 in DMD	A Phase II, Open-Label, Extension Study of NS-089/NCNP-02in Patients With Duchenne Muscular Dystroph ...	Duchenne Muscular Dystrophy (DMD)	Drug: NS-089/NCNP-02	Nippon Shinyaku Co., Ltd.	NULL	Active, not recruiting	N/A	N/A	Male	6	Phase 2	Japan
2	NCT04129294 (ClinicalTrials.gov)	December 2, 2019	15/10/2019	Exploratory Study of NS-089/NCNP-02 in DMD	Exploratory Study of NS-089/NCNP-02 in Duchenne Muscular Dystrophy	Duchenne Muscular Dystrophy	Drug: NS-089/NCNP-02	National Center of Neurology and Psychiatry, Japan	Nippon Shinyaku Co., Ltd.	Completed	4 Years	17 Years	Male	6	Phase 1/Phase 2	Japan

First Previous1Next Last